“Time” for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment
Seminars in Cancer Biology · 2023-06 · 91 · 99-109
DOI: 10.1016/j.semcancer.2023.03.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023-06. Verfasst von Caterina Miro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy. Hauptthemen laut MEDLINE: Circadian Rhythm, Thyroid Neoplasms. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The circadian rhythm is regulated by an intrinsic time-tracking system, composed both of a central and a peripheral clock, which influences the cycles of activities and sleep of an individual over 24 h. At the molecular level, the circadian rhythm begins when two basic helix-loop-helix/Per-ARNT-SIM (bHLH-PAS) proteins, BMAL-1 and CLOCK, interact with each other to produce BMAL-1/CLOCK heterodimers in the cytoplasm. The BMAL-1/CLOCK target genes encode for the repressor components of the clock, cryptochrome (Cry1 and Cry2) and the Period proteins (Per1, Per2 and Per3). It has been recently demonstrated that the disruption of circadian rhythm is associated with an increased risk of developing obesity and obesity-related diseases. In addition, it has been demonstrated that the disruption of the circadian rhythm plays a key role in tumorigenesis. Further, an association between the circadian rhythm disruptions and an increased incidence and progression of several types of cancer (e.g., breast, prostate, colorectal and thyroid cancer) has been found. As the perturbation of circadian rhythm has adverse metabolic consequences (e.g., obesity) and at the same time tumor promoter functions, this manuscript has the aim to report how the aberrant circadian rhythms affect the development and prognosis of different types of obesity-related cancers (breast, prostate, colon rectal and thyroid cancer) focusing on both human studies and on molecular aspects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.
- Dipartimento di Medicina Clinica e Chirurgia, Unità di Endocrinologia, Diabetologia ed Andrologia, Università Federico II, Naples, Italy.
- Dipartimento di Scienze Umanistiche, Università Telematica Pegaso, 80143 Naples, Italy.
- Department of Public Health, University of Federico II, 80131 Naples, Italy.
- George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mures/Internal Medicine I, Târgu Mureş, Romania; Diabetes, Nutrition and Metabolic Diseases Outpatient Unit, Emergency County Clinica…
- National Centre for Infertility and Endocrinology of Gender, Clinic for Endocrinology Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, Serbia.
Zitieren
APA
Miro, C., Docimo, A., Barrea, L., Verde, L., Cernea, S., Sojat, A. S., Marina, L. V., Docimo, G., Colao, A., Dentice, M., & Muscogiuri, G. (2023). “Time” for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment. Seminars in Cancer Biology, 91, 99-109. https://doi.org/10.1016/j.semcancer.2023.03.003
Vancouver
Miro C, Docimo A, Barrea L, Verde L, Cernea S, Sojat AS, et al. “Time” for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment. Seminars in Cancer Biology. 2023;91:99-109. doi:10.1016/j.semcancer.2023.03.003
BibTeX
@article{Miro2023,
author = {Miro, Caterina and Docimo, Annamaria and Barrea, Luigi and Verde, Ludovica and Cernea, Simona and Sojat, Antoan Stefan and Marina, Ljiljana V and Docimo, Giovanni and Colao, Annamaria and Dentice, Monica and Muscogiuri, Giovanna},
title = {“Time” for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment},
journal = {Seminars in Cancer Biology},
year = {2023},
volume = {91},
pages = {99--109},
doi = {10.1016/j.semcancer.2023.03.003}
}
EUVIMED